JJ Kang, Ph.D.
CEO and Co-Founder of Appia Bio, Venture Partner at The Column Group
JJ Kang, PhD, is co-founder and CEO of Appia Bio and a venture partner at The Column Group since 2020. JJ held roles of increasing responsibility on the investment team at The Column Group since joining in 2015 and last served as a partner prior to founding Appia Bio. Previously, she worked at FibroGen in project management and corporate strategy. She serves on the boards of directors of Tenaya Therapeutics and Escient Pharmaceuticals. JJ earned a PhD in chemical biology at Caltech and a BA in chemistry from Harvard University.